Ann-Sofie Rudberg1, Eivind Berge2,3, Anders Gustavsson4,5, Per Näsman6, Erik Lundström1. 1. 1Department of Clinical Neuroscience, Division of Neurology, Karolinska Institutet, Stockholm, Sweden. 2. Department of Internal Medicine and Cardiology, Oslo University Hospital, Oslo, Norway. 3. Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway. 4. Quantify Research, Stockholm, Sweden. 5. Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. 6. Center for Safety Research, KTH Royal Institute of Technology, Stockholm, Sweden.
Abstract
INTRODUCTION: Information about the impact of functional outcome after stroke is currently missing on health-related quality of life, survival and costs. This information would be valuable for health economic evaluations and for allocation of resources in stroke health care. PATIENTS AND METHODS: Data on 297 Swedish patients included in the Third International Stroke Trial were analysed including functional outcome at six months (measured by Oxford Handicap Scale), health-related quality of life up to 18 months (EQ-5D-3L) and survival up to 36 months. We used record linkage to collect data on costs up to 36 months, using national patient registers. RESULTS: Patients with a better functional outcome level at six months had a significantly better health-related quality of life at 18 months (p < 0.05), better long-term survival (p < 0.05) and lower costs (p < 0.001), for all time points up to 36 months. The difference in costs was mainly due to differences in days spent in hospital (p < 0.005). DISCUSSION: This study showed an association between functional outcome at six months and health-related quality of life up to 18 months, and costs up to 36 months. CONCLUSION: Functional outcome six months after stroke is an important determinant of health-related quality of life, survival and costs over 36 months. Effective interventions aimed at reducing short-term disability levels are therefore also expected to reduce the overall burden of stroke.
INTRODUCTION: Information about the impact of functional outcome after stroke is currently missing on health-related quality of life, survival and costs. This information would be valuable for health economic evaluations and for allocation of resources in stroke health care. PATIENTS AND METHODS: Data on 297 Swedish patients included in the Third International Stroke Trial were analysed including functional outcome at six months (measured by Oxford Handicap Scale), health-related quality of life up to 18 months (EQ-5D-3L) and survival up to 36 months. We used record linkage to collect data on costs up to 36 months, using national patient registers. RESULTS: Patients with a better functional outcome level at six months had a significantly better health-related quality of life at 18 months (p < 0.05), better long-term survival (p < 0.05) and lower costs (p < 0.001), for all time points up to 36 months. The difference in costs was mainly due to differences in days spent in hospital (p < 0.005). DISCUSSION: This study showed an association between functional outcome at six months and health-related quality of life up to 18 months, and costs up to 36 months. CONCLUSION: Functional outcome six months after stroke is an important determinant of health-related quality of life, survival and costs over 36 months. Effective interventions aimed at reducing short-term disability levels are therefore also expected to reduce the overall burden of stroke.
Entities:
Keywords:
EQ-5D; Stroke; functional level; health economy; quality adjusted life year; survival
Authors: Jesse Dawson; Jennifer S Lees; Tou-Pin Chang; Matthew R Walters; Myzoon Ali; Stephen M Davis; Hans-Christoph Diener; Kennedy R Lees Journal: Stroke Date: 2007-04-19 Impact factor: 7.914
Authors: M C Christensen; I Previgliano; F J Capparelli; D Lerman; W C Lee; N A Wainsztein Journal: Acta Neurol Scand Date: 2008-09-01 Impact factor: 3.209